GANX vs RL · $53.0M cap vs P/E 24, rev $8.11B
Gain Therapeutics Inc (GANX) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Gain Therapeutics Inc (GANX) is a biotechnology company listed on US.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
GANX does not have a complete income-statement cache yet.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
GANX currently screens at market cap $53.0M. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the GANX and RL stock pages for the full models.
Not investment advice.